1,504 results on '"Vincenzi, Bruno"'
Search Results
202. Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)
203. Bisphosphonate Effects in Cancer and Inflammatory Diseases: In Vitro and In Vivo Modulation of Cytokine Activities
204. Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: A multicenter non-randomized phase II study
205. Effective tyrosine kinase inhibitor re-treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer patient: a case report
206. The Role of Bone Microenvironment, Vitamin D and Calcium
207. The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients
208. The variation in treating colorectal cancer between Europe and America
209. Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level
210. Gene Signatures and Soft Tissue Sarcomas: Status of Art and Perspectives
211. Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma
212. Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence
213. Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal
214. Aromatase Inhibitor Exemestane has Antiproliferative Effects on Human Mesothelioma Cells
215. Chapter 26 - Novel Biomarkers Predicting the Development of Bone Metastasis in Early Breast Cancer
216. Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study
217. Combination of bleomycin and cisplatin as adjuvant electrochemotherapy protocol for the treatment of incompletely excised feline injection-site sarcomas: A retrospective study
218. Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case‐series analysis within the Italian Rare Cancer Network
219. The Experience of Oncology Healthcare Providers in the Central Italy during the COVID-19 Lockdown
220. Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
221. Denosumab for cancer-related bone loss
222. Definition of a Novel Plasmid-Based Gene Transfection Protocol of Mammalian Skeletal Muscles by Means of In Vivo Electroporation
223. Steroid-refractory immune related hepatitis may hide viral re-activation
224. Recent Advances in Desmoid Tumor Therapy
225. TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy
226. The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis
227. COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management
228. Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
229. Facing SARS-CoV-2 outbreak in immunotherapy era
230. Current and Emerging Biomarkers Predicting Bone Metastasis Development
231. Update of NGS analysis of Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor).
232. Identification of SDHA germline mutations in sporadic SDHA mutant gastrointestinal stromal tumors (GIST): The need of a genetic counselling.
233. Role of adjuvant imatinib dose in radically resected GIST harboring KIT exon 9 mutations.
234. TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with anti-angiogenic or standard chemotherapy regimens.
235. Breakthrough cancer pain clinical features and differential opioids response: A machine learning approach in 4,016 cancer patients of IOPS-MS study.
236. Role of glyoxalase-1 in trabectedin-resistant myxoid liposarcoma.
237. Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST
238. Prognostic and predictive factors in pancreatic cancer
239. Semi-ResMass Study: Residual masses after salvage chemotherapy in men with pure seminoma—A multicenter retrospective analysis.
240. Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab
241. Regression of Papillary Thyroid Cancer during Nivolumab for Renal Cell Cancer
242. Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?
243. Familial adenomatosis polyposis–related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis
244. Identification of Aneuploid Circulating Tumor Cells in Soft-Tissue Sarcoma Patients: A Pilot Study
245. Aprepitant for Erlotinib-Induced Pruritus
246. Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy
247. Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer
248. Aprepitant for Erlotinib-Induced Pruritus
249. Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives
250. ‘If it is not recorded, it has not been done!’? consistency between nursing records and observed nursing care in an Italian hospital
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.